Those rates seem low ,do you mean the international liver congress which is being held in Vienna now?
Had a quick google and from what I read real world data sows svr4 at 100% with SOF/RIB/DCV
AT BOTH 12 and 24 weeks could not see any svr12 or 24 data tho
This was for genotype 1 cirrhotics
However it did mention serious adverse events in 9% of patients and discontinuation of treatment in 3% of patients
JLynch30 said
Apr 25, 2015
did anyone read the 2015 european liver meeting abstrcts. The numbers of svr ofr cirhotics who failed treatmentlook arounf 88%
This is far lower than the original numbers. Is this the real worldnumbers?
SVR12 rates were 68% in patients without cirrhosis and 74% in those with cirrhosis.
Had a quick google and from what I read real world data sows svr4 at 100% with SOF/RIB/DCV
AT BOTH 12 and 24 weeks could not see any svr12 or 24 data tho
This was for genotype 1 cirrhotics
However it did mention serious adverse events in 9% of patients and discontinuation of treatment in 3% of patients
did anyone read the 2015 european liver meeting abstrcts. The numbers of svr ofr cirhotics who failed treatmentlook arounf 88%
This is far lower than the original numbers. Is this the real worldnumbers?
SVR12 rates were 68% in patients without cirrhosis and 74% in those with cirrhosis.